VITALHUB CORP (VHI.CA) Stock Fundamental Analysis
TSX:VHI - Toronto Stock Exchange - CA92847V5018 - Common Stock - Currency: CAD
Overall VHI gets a fundamental rating of 6 out of 10. We evaluated VHI against 8 industry peers in the Health Care Technology industry. VHI scores excellent points on both the profitability and health parts. This is a solid base for a good stock. VHI is growing strongly while it is still valued neutral. This is a good combination! This makes VHI very considerable for growth and quality investing!
1. Profitability
1.1 Basic Checks
In the past year VHI was profitable.
VHI had a positive operating cash flow in the past year.
In multiple years VHI reported negative net income over the last 5 years.
Of the past 5 years VHI 4 years had a positive operating cash flow.
1.2 Ratios
With an excellent Return On Assets value of 1.45%, VHI belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Looking at the Return On Equity, with a value of 2.07%, VHI belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
With an excellent Return On Invested Capital value of 3.93%, VHI belongs to the best of the industry, outperforming 87.50% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for VHI is in line with the industry average of 4.32%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.45% | ||
| ROE | 2.07% | ||
| ROIC | 3.93% |
ROA(3y)2.14%
ROA(5y)0.07%
ROE(3y)3.08%
ROE(5y)0.28%
ROIC(3y)3.96%
ROIC(5y)N/A
1.3 Margins
VHI has a Profit Margin of 4.37%. This is amongst the best in the industry. VHI outperforms 100.00% of its industry peers.
VHI has a Operating Margin of 13.68%. This is amongst the best in the industry. VHI outperforms 100.00% of its industry peers.
VHI's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 80.90%, VHI belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
VHI's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.68% | ||
| PM (TTM) | 4.37% | ||
| GM | 80.9% |
OM growth 3Y125.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5Y2.08%
2. Health
2.1 Basic Checks
VHI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
VHI has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, VHI has more shares outstanding
VHI has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 6.29 indicates that VHI is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 6.29, VHI belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
VHI has a debt to FCF ratio of 0.04. This is a very positive value and a sign of high solvency as it would only need 0.04 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.04, VHI belongs to the best of the industry, outperforming 87.50% of the companies in the same industry.
VHI has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
VHI has a better Debt to Equity ratio (0.00) than 87.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.04 | ||
| Altman-Z | 6.29 |
ROIC/WACC0.42
WACC9.27%
2.3 Liquidity
VHI has a Current Ratio of 1.70. This is a normal value and indicates that VHI is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.70, VHI is doing good in the industry, outperforming 62.50% of the companies in the same industry.
VHI has a Quick Ratio of 1.69. This is a normal value and indicates that VHI is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of VHI (1.69) is better than 62.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.7 | ||
| Quick Ratio | 1.69 |
3. Growth
3.1 Past
VHI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -36.36%.
VHI shows a strong growth in Revenue. In the last year, the Revenue has grown by 30.64%.
VHI shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 46.32% yearly.
EPS 1Y (TTM)-36.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)30.64%
Revenue growth 3Y40.63%
Revenue growth 5Y46.32%
Sales Q2Q%51.37%
3.2 Future
Based on estimates for the next years, VHI will show a very strong growth in Earnings Per Share. The EPS will grow by 82.32% on average per year.
VHI is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 26.69% yearly.
EPS Next Y215.37%
EPS Next 2Y107.06%
EPS Next 3Y82.32%
EPS Next 5YN/A
Revenue Next Year30.64%
Revenue Next 2Y19.52%
Revenue Next 3Y26.69%
Revenue Next 5YN/A
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
VHI is valuated quite expensively with a Price/Earnings ratio of 148.86.
100.00% of the companies in the same industry are more expensive than VHI, based on the Price/Earnings ratio.
VHI's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 25.91.
A Price/Forward Earnings ratio of 47.20 indicates a quite expensive valuation of VHI.
100.00% of the companies in the same industry are more expensive than VHI, based on the Price/Forward Earnings ratio.
VHI's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 21.85.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 148.86 | ||
| Fwd PE | 47.2 |
4.2 Price Multiples
87.50% of the companies in the same industry are more expensive than VHI, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, VHI is valued cheaper than 87.50% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 40.81 | ||
| EV/EBITDA | 34.23 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of VHI may justify a higher PE ratio.
A more expensive valuation may be justified as VHI's earnings are expected to grow with 82.32% in the coming years.
PEG (NY)0.69
PEG (5Y)N/A
EPS Next 2Y107.06%
EPS Next 3Y82.32%
5. Dividend
5.1 Amount
VHI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:VHI (5/22/2025, 7:00:00 PM)
10.42
+0.13 (+1.26%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners30.84%
Inst Owner ChangeN/A
Ins Owners12.77%
Ins Owner ChangeN/A
Market Cap581.23M
Analysts81.67
Price Target14.09 (35.22%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-29.87%
Min EPS beat(2)-33.99%
Max EPS beat(2)-25.74%
EPS beat(4)0
Avg EPS beat(4)-53.99%
Min EPS beat(4)-130.46%
Max EPS beat(4)-25.74%
EPS beat(8)1
Avg EPS beat(8)-27.09%
EPS beat(12)2
Avg EPS beat(12)-30.49%
EPS beat(16)2
Avg EPS beat(16)-91.06%
Revenue beat(2)1
Avg Revenue beat(2)1.93%
Min Revenue beat(2)-0.84%
Max Revenue beat(2)4.69%
Revenue beat(4)3
Avg Revenue beat(4)3.33%
Min Revenue beat(4)-0.84%
Max Revenue beat(4)5.76%
Revenue beat(8)6
Avg Revenue beat(8)3.33%
Revenue beat(12)9
Avg Revenue beat(12)3.85%
Revenue beat(16)11
Avg Revenue beat(16)2.87%
PT rev (1m)0%
PT rev (3m)2.95%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-7.16%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.29%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.95%
Revenue NY rev (1m)2.35%
Revenue NY rev (3m)2.25%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 148.86 | ||
| Fwd PE | 47.2 | ||
| P/S | 8.47 | ||
| P/FCF | 40.81 | ||
| P/OCF | 38.42 | ||
| P/B | 4.01 | ||
| P/tB | 35.46 | ||
| EV/EBITDA | 34.23 |
EPS(TTM)0.07
EY0.67%
EPS(NY)0.22
Fwd EY2.12%
FCF(TTM)0.26
FCFY2.45%
OCF(TTM)0.27
OCFY2.6%
SpS1.23
BVpS2.6
TBVpS0.29
PEG (NY)0.69
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.45% | ||
| ROE | 2.07% | ||
| ROCE | 5.76% | ||
| ROIC | 3.93% | ||
| ROICexc | 6.02% | ||
| ROICexgc | N/A | ||
| OM | 13.68% | ||
| PM (TTM) | 4.37% | ||
| GM | 80.9% | ||
| FCFM | 20.76% |
ROA(3y)2.14%
ROA(5y)0.07%
ROE(3y)3.08%
ROE(5y)0.28%
ROIC(3y)3.96%
ROIC(5y)N/A
ROICexc(3y)5.88%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)5.82%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y132.1%
ROICexc growth 5YN/A
OM growth 3Y125.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5Y2.08%
F-Score4
Asset Turnover0.33
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.04 | ||
| Debt/EBITDA | 0.02 | ||
| Cap/Depr | 14.82% | ||
| Cap/Sales | 1.29% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 98.57% | ||
| Profit Quality | 474.99% | ||
| Current Ratio | 1.7 | ||
| Quick Ratio | 1.69 | ||
| Altman-Z | 6.29 |
F-Score4
WACC9.27%
ROIC/WACC0.42
Cap/Depr(3y)9.42%
Cap/Depr(5y)8.61%
Cap/Sales(3y)0.86%
Cap/Sales(5y)0.89%
Profit Quality(3y)466.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-36.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y215.37%
EPS Next 2Y107.06%
EPS Next 3Y82.32%
EPS Next 5YN/A
Revenue 1Y (TTM)30.64%
Revenue growth 3Y40.63%
Revenue growth 5Y46.32%
Sales Q2Q%51.37%
Revenue Next Year30.64%
Revenue Next 2Y19.52%
Revenue Next 3Y26.69%
Revenue Next 5YN/A
EBIT growth 1Y52.67%
EBIT growth 3Y217.15%
EBIT growth 5YN/A
EBIT Next Year65.66%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-29.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-26.11%
OCF growth 3YN/A
OCF growth 5YN/A